spire patient journey booklet

• Spire Manuals
• Medical Equipment
• Medical Health Tag
• Patient instruction booklet

Spire Medical Health Tag Patient Instruction Booklet

• page of 21 Go / 21

Table of Contents

• App Notifications
• Important Notes
• Frequently Asked Questions
• Indications for Use
• Environmental Characteristics
• Electrical Safety and Compatibility

Advertisement

Quick Links

Summary of contents for spire medical health tag.

• Page 1 RELEASED IFU002 Rev C.0 Effective Date: 2019-10-17 Patient Instruction Booklet Welcome to Spire Health! Medical Health Tags help your doctor understand changes in your health and wellness while you’re at home. Medical Health Tags also promote healthier habits like increased activity and sleep which can contribute to improvements in your condition.
• Page 2 • You’ll need your Medical Health Tags and undergarments you wear most frequently ready for this step. • You only need to pair (connect) one Medical Health Tag with the App. The rest of your Medical Health Tags in your pack will pair automatically.
• Page 3 Spire Health App. They are also included below for your reference: For each piece of clothing, remove the adhesive strip from the back of the Medical Health Tag and position it on clothing as shown below. Underwear: place 1-2 inches Bras: place ½...
• Page 4 IFU002 Rev C.0 Effective Date: 2019-10-17 Understanding the App It is important that you wear a Medical Health Tag as often as possible. Use your to confirm that your device is being worn correctly. The different screens you may see are shown below:...
• Page 5 Make sure the soft side of the Make sure you are wearing a Medical Health Tag is in contact Medical Health Tag. with your skin. If you cannot resolve these errors, contact Spire Health customer support at (415) 980-3858 Spire, Inc. Confidential & Proprietary IFU002 Rev C.0...

Page 6: App Notifications

• Page 7 Your Medical Health Tags have a long battery life that does not require charging. When a Medical Health Tag has reached the end of its battery life, you will need to remove it and replace it with a new device.
• Page 8 IFU002 Rev C.0 Effective Date: 2019-10-17 Replacement Adhesive If for any reason, your Medical Health Tag comes off of your garment before it is ready to be replaced, you can re-attach it using the Medical Health Tag adhesives included in your kit.

Page 9: Important Notes

Page 10: frequently asked questions.

• Page 11 ● Do not launder Medical Health Tags on hot settings (>140°F) or with bleach or fabric softener or device may become damaged. ● Do not wear or use a Medical Health Tag that has been damaged. ● The Medical Health Tags are magnetic resonance (MR) unsafe! Do not expose Medical Health Tags to a MR environment.

Page 12: Need Help

Page 13: indications for use.

• Page 14 RELEASED IFU002 Rev C.0 Effective Date: 2019-10-17 Spire Health 2030 Harrison Street San Francisco, CA 94110 Tel: +1-800-501-2256 (USA Only) SYMBOLS Date of Manufacturer Use-by-date Manufacture Type BF Prescription Net Quantity Applied Part Use Only of Contents Catalog Batch Code...
• Page 15 Battery Type 1 Lithium Manganese Coin Cell Battery Life Minimum of 500 hours of use PHYSICAL CHARACTERISTICS Dimensions 55mm x 34mm x 9mm Weight Spire, Inc. Confidential & Proprietary IFU002 Rev C.0 Instructions for Use Page 15 of 20 Patient Manual...

Page 16: Environmental Characteristics

• Page 17 Table 2: Guidance and manufacturer’s declaration— electromagnetic immunity The Medical Health Tag device is intended for use in the electromagnetic environment specified below. The customer or the user of the Medical Health Tag device should assure that it is used in such an environment.
• Page 18 RF transmitters, an electromagnetic site survey should be considered. If the measured field strength in the location in which the Medical Health Tag is used exceeds the applicable RF compliance level above, the Medical Health Tag should be observed to verify normal operation.
• Page 19 The Medical Health Tag is intended for use in an electromagnetic environment in which radiated RF disturbances are controlled. The customer or the user of the Medical Health Tag can help prevent electromagnetic interference by maintaining a minimum distance between...
• Page 20 Trademarks Spire®, the Spire wave, and the Spire Medical Health Tag are registered trademarks of Spire, Inc. The Bluetooth® wordmark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Spire, Inc.

This manual is also suitable for:

Rename the bookmark, delete bookmark, delete from my manuals, upload manual.

• Search Menu
• Advance Articles
• Editor's Choice
• Supplements
• Patient Perspectives
• Methods Corner
• ESC Content Collections
• Author Guidelines
• Instructions for reviewers
• Submission Site
• Why publish with EJCN?
• Open Access Options
• Self-Archiving Policy
• Read & Publish
• About European Journal of Cardiovascular Nursing
• About ACNAP
• About European Society of Cardiology
• ESC Publications
• Editorial Board
• Advertising & Corporate Services
• War in Ukraine
• Journals on Oxford Academic
• Books on Oxford Academic

Article Contents

Introduction, why patient journey mapping, how is patient journey mapping conducted, use of technology in patient journey mapping, future implications for patient journey mapping, conclusions, patient journey mapping: emerging methods for understanding and improving patient experiences of health systems and services.

Lemma N Bulto and Ellen Davies Shared first authorship.

Conflict of interest: none declared.

• Article contents
• Figures & tables
• Supplementary Data

Lemma N Bulto, Ellen Davies, Janet Kelly, Jeroen M Hendriks, Patient journey mapping: emerging methods for understanding and improving patient experiences of health systems and services, European Journal of Cardiovascular Nursing , 2024;, zvae012, https://doi.org/10.1093/eurjcn/zvae012

• Permissions Icon Permissions

Patient journey mapping is an emerging field of research that uses various methods to map and report evidence relating to patient experiences and interactions with healthcare providers, services, and systems. This research often involves the development of visual, narrative, and descriptive maps or tables, which describe patient journeys and transitions into, through, and out of health services. This methods corner paper presents an overview of how patient journey mapping has been conducted within the health sector, providing cardiovascular examples. It introduces six key steps for conducting patient journey mapping and describes the opportunities and benefits of using patient journey mapping and future implications of using this approach.

Acquire an understanding of patient journey mapping and the methods and steps employed.

Examine practical and clinical examples in which patient journey mapping has been adopted in cardiac care to explore the perspectives and experiences of patients, family members, and healthcare professionals.

Quality and safety guidelines in healthcare services are increasingly encouraging and mandating engagement of patients, clients, and consumers in partnerships. 1 The aim of many of these partnerships is to consider how health services can be improved, in relation to accessibility, service delivery, discharge, and referral. 2 , 3 Patient journey mapping is a research approach increasingly being adopted to explore these experiences in healthcare. 3

a patient-oriented project that has been undertaken to better understand barriers, facilitators, experiences, interactions with services and/or outcomes for individuals and/or their carers, and family members as they enter, navigate, experience and exit one or more services in a health system by documenting elements of the journey to produce a visual or descriptive map. 3

It is an emerging field with a clear patient-centred focus, as opposed to studies that track patient flow, demand, and movement. As a general principle, patient journey mapping projects will provide evidence of patient perspectives and highlight experiences through the patient and consumer lens.

Patient journey mapping can provide significant insights that enable responsive and context-specific strategies for improving patient healthcare experiences and outcomes to be designed and implemented. 3–6 These improvements can occur at the individual patient, model of care, and/or health system level. As with other emerging methodologies, questions have been raised regarding exactly how patient journey mapping projects can best be designed, conducted, and reported. 3

In this methods paper, we provide an overview of patient journey mapping as an emergent field of research, including reasons that mapping patient journeys might be considered, methods that can be adopted, the principles that can guide patient journey mapping data collection and analysis, and considerations for reporting findings and recognizing the implications of findings. We summarize and draw on five cardiovascular patient journey mapping projects, as examples.

One of the most appealing elements of the patient journey mapping field of research is its focus on illuminating the lived experiences of patients and/or their family members, and the health professionals caring for them, methodically and purposefully. Patient journey mapping has an ability to provide detailed information about patient experiences, gaps in health services, and barriers and facilitators for access to health services. This information can be used independently, or alongside information from larger data sets, to adapt and improve models of care relevant to the population that is being investigated. 3

To date, the most frequent reason for adopting this approach is to inform health service redesign and improvement. 3 , 7 , 8 Other reasons have included: (i) to develop a deeper understanding of a person’s entire journey through health systems; 3 (ii) to identify delays in diagnosis or treatment (often described as bottlenecks); 9 (iii) to identify gaps in care and unmet needs; (iv) to evaluate continuity of care across health services and regions; 10 (v) to understand and evaluate the comprehensiveness of care; 11 (vi) to understand how people are navigating health systems and services; and (vii) to compare patient experiences with practice guidelines and standards of care.

Patient journey mapping approaches frequently use six broad steps that help facilitate the preparation and execution of research projects. These are outlined in the Central illustration . We acknowledge that not all patient journey mapping approaches will follow the order outlined in the Central illustration , but all steps need to be considered at some point throughout each project to ensure that research is undertaken rigorously, appropriately, and in alignment with best practice research principles.

Steps for conducing patient journey mapping.

Five cardiovascular patient journey mapping research examples have been included in Figure 1 , 12–16 to provide specific context and illustrate these six steps. For each of these examples, the problem or gap in practice or research, consultation processes, research question or aim, type of mapping, methods, and reporting of findings have been extracted. Each of these steps is then discussed, using these cardiovascular examples.

Examples of patient journey mapping projects.

Define the problem or gap in practice or research

Developing an understanding of a problem or gap in practice is essential for facilitating the design and development of quality research projects. In the examples outlined in Figure 1 , it is evident that clinical variation or system gaps have been explored using patient journey mapping. In the first two examples, populations known to have health vulnerabilities were explored—in Example 1, this related to comorbid substance use and physical illness, 13 and in Example 2, this related to geographical location. 13 Broader systems and societal gaps were explored in Examples 4 and 5, respectively, 15 , 16 and in Example 3, a new technologically driven solution for an existing model of care was tested for its ability to improve patient outcomes relating to hypertension. 14

Consultation, engagement, and partnership

Ideally, consultation with heathcare providers and/or patients would occur when the problem or gap in practice or research is being defined. This is a key principle of co-designed research. 17 Numerous existing frameworks for supporting patient involvement in research have been designed and were recently documented and explored in a systematic review by Greenhalgh et al . 18 While none of the five example studies included this step in the initial phase of the project, it is increasingly being undertaken in patient partnership projects internationally (e.g. in renal care). 17 If not in the project conceptualization phase, consultation may occur during the data collection or analysis phase, as demonstrated in Example 3, where a care pathway was co-created with participants. 14 We refer readers to Greenhalgh’s systematic review as a starting point for considering suitable frameworks for engaging participants in consultation, partnership, and co-design of patient journey mapping projects. 18

Design the research question/project aim

Conducting patient journey mapping research requires a thoughtful and systematic approach to adequately capture the complexity of the healthcare experience. First, the research objectives and questions should be clearly defined. Aspects of the patient journey that will be explored need to be identified. Then, a robust approach must be developed, taking into account whether qualitative, quantitative, or mixed methods are more appropriate for the objectives of the study.

For example, in the cardiac examples in Figure 1 , the broad aims included mapping existing pathways through health services where there were known problems 12 , 13 , 15 , 16 and documenting the co-creation of a new care pathway using quantitative, qualitative, or mixed methods. 14

In traditional studies, questions that might be addressed in the area of patient movement in health systems include data collected through the health systems databases, such as ‘What is the length of stay for x population’, or ‘What is the door to balloon time in this hospital?’ In contrast, patient mapping journey studies will approach asking questions about experiences that require data from patients and their family members, e.g. ‘What is the impact on you of your length of stay?’, ‘What was your experience in being assessed and undergoing treatment for your chest pain?’, ‘What was your experience supporting this patient during their cardiac admission and discharge?’

Select appropriate type of mapping

The methods chosen for mapping need to align with the identified purpose for mapping and the aim or question that was designed in Step 3. A range of research methods have been used in patient journey mapping projects involving various qualitative, quantitative, and mixed methods techniques and tools. 4 Some approaches use traditional forms of data collection, such as short-form and long-form patient interviews, focus groups, and direct patient observations. 18 , 19 Other approaches use patient journey mapping tools, designed and used with specific cultural groups, such as First Nations peoples using artwork, paintings, sand trays, and photovoice. 17 , 20 In the cardiovascular examples presented in Figure 1 , both qualitative and quantitative methods have been used, with interviews, patient record reviews, and observational techniques adopted to map patient journeys.

In a recent scoping review investigating patient journey mapping across all health care settings and specialities, six types of patient journey mapping were identified. 3 These included (i) mapping key experiences throughout a period of illness; (ii) mapping by location of health service; (iii) mapping by events that occurred throughout a period of illness; (iv) mapping roles, input, and experiences of key stakeholders throughout patient journeys; (v) mapping a journey from multiple perspectives; and (vi) mapping a timeline of events. 3 Combinations or variations of these may be used in cardiovascular settings in the future, depending on the research question, and the reasons mapping is being undertaken.

Recruit, collect data, and analyse data

The majority of health-focused patient journey mapping projects published to date have recruited <50 participants. 3 Projects with fewer participants tend to be qualitative in nature. In the cardiovascular examples provided in Figure 1 , participant numbers range from 7 14 to 260. 15 The 3 studies with <20 participants were qualitative, 12 , 14 , 16 and the 2 with 95 and 260 participants, respectively, were quantitative. 13 , 15 As seen in these and wider patient journey mapping examples, 3 participants may include patients, relatives, carers, healthcare professionals, or other stakeholders, as required, to meet the study objectives. These different participant perspectives may be analysed within each participant group and/or across the wider cohort to provide insights into experiences, and the contextual factors that shape these experiences.

The approach chosen for data collection and analysis will vary and depends on the research question. What differentiates data analysis in patient journey mapping studies from other qualitative or quantitative studies is the focus on describing, defining, or exploring the journey from a patient’s, rather than a health service, perspective. Dimensions that may, therefore, be highlighted in the analysis include timing of service access, duration of delays to service access, physical location of services relative to a patient’s home, comparison of care received vs. benchmarked care, placing focus on the patient perspective.

The mapping of individual patient journeys may take place during data collection with the use of mapping templates (tables, diagrams, and figures) and/or later in the analysis phase with the use of inductive or deductive analysis, mapping tables, or frameworks. These have been characterized and visually represented in a recent scoping review. 3 Representations of patient journeys can also be constructed through a secondary analysis of previously collected data. In these instances, qualitative data (i.e. interviews and focus group transcripts) have been re-analysed to understand whether a patient journey narrative can be extracted and reported. Undertaking these projects triggers a new research cycle involving the six steps outlined in the Central illustration . The difference in these instances is that the data are already collected for Step 5.

Report findings, disseminate findings, and take action on findings

A standardized, formal reporting guideline for patient journey mapping research does not currently exist. As argued in Davies et al ., 3 a dedicated reporting guide for patient journey mapping would be ill-advised, given the diversity of approaches and methods that have been adopted in this field. Our recommendation is for projects to be reported in accordance with formal guidelines that best align with the research methods that have been adopted. For example, COREQ may be used for patient journey mapping where qualitative methods have been used. 20 STROBE may be used for patient journey mapping where quantitative methods have been used. 21 Whichever methods have been adopted, reporting of projects should be transparent, rigorous, and contain enough detail to the extent that the principles of transparency, trustworthiness, and reproducibility are upheld. 3

Dissemination of research findings needs to include the research, healthcare, and broader communities. Dissemination methods may include academic publications, conference presentations, and communication with relevant stakeholders including healthcare professionals, policymakers, and patient advocacy groups. Based on the findings and identified insights, stakeholders can collaboratively design and implement interventions, programmes, or improvements in healthcare delivery that overcome the identified challenges directly and address and improve the overall patient experience. This cyclical process can hopefully produce research that not only informs but also leads to tangible improvements in healthcare practice and policy.

Patient journey mapping is typically a hands-on process, relying on surveys, interviews, and observational research. The technology that supports this research has, to date, included word processing software, and data analysis packages, such as NVivo, SPSS, and Stata. With the advent of more sophisticated technological tools, such as electronic health records, data analytics programmes, and patient tracking systems, healthcare providers and researchers can potentially use this technology to complement and enhance patient journey mapping research. 19 , 20 , 22 There are existing examples where technology has been harnessed in patient journey. Lee et al . used patient journey mapping to verify disease treatment data from the perspective of the patient, and then the authors developed a mobile prototype that organizes and visualizes personal health information according to the patient-centred journey map. They used a visualization approach for analysing medical information in personal health management and examined the medical information representation of seven mobile health apps that were used by patients and individuals. The apps provide easy access to patient health information; they primarily import data from the hospital database, without the need for patients to create their own medical records and information. 23

In another example, Wauben et al. 19 used radio frequency identification technology (a wireless system that is able to track a patient journey), as a component of their patient journey mapping project, to track surgical day care patients to increase patient flow, reduce wait times, and improve patient and staff satisfaction.

Patient journey mapping has emerged as a valuable research methodology in healthcare, providing a comprehensive and patient-centric approach to understanding the entire spectrum of a patient’s experience within the healthcare system. Future implications of this methodology are promising, particularly for transforming and redesigning healthcare delivery and improving patient outcomes. The impact may be most profound in the following key areas:

Personalized, patient-centred care : The methodology allows healthcare providers to gain deep insights into individual patient experiences. This information can be leveraged to deliver personalized, patient-centric care, based on the needs, values, and preferences of each patient, and aligned with guideline recommendations, healthcare professionals can tailor interventions and treatment plans to optimize patient and clinical outcomes.

Enhanced communication, collaboration, and co-design : Mapping patient interactions with health professionals and journeys within and across health services enables specific gaps in communication and collaboration to be highlighted and potentially informs responsive strategies for improvement. Ideally, these strategies would be co-designed with patients and health professionals, leading to improved care co-ordination and healthcare experience and outcomes.

Patient engagement and empowerment : When patients are invited to share their health journey experiences, and see visual or written representations of their journeys, they may come to understand their own health situation more deeply. Potentially, this may lead to increased health literacy, renewed adherence to treatment plans, and/or self-management of chronic conditions such as cardiovascular disease. Given these benefits, we recommend that patients be provided with the findings of research and quality improvement projects with which they are involved, to close the loop, and to ensure that the findings are appropriately disseminated.

Patient journey mapping is an emerging field of research. Methods used in patient journey mapping projects have varied quite significantly; however, there are common research processes that can be followed to produce high-quality, insightful, and valuable research outputs. Insights gained from patient journey mapping can facilitate the identification of areas for enhancement within healthcare systems and inform the design of patient-centric solutions that prioritize the quality of care and patient outcomes, and patient satisfaction. Using patient journey mapping research can enable healthcare providers to forge stronger patient–provider relationships and co-design improved health service quality, patient experiences, and outcomes.

None declared.

Farmer   J , Bigby   C , Davis   H , Carlisle   K , Kenny   A , Huysmans   R , et al.    The state of health services partnering with consumers: evidence from an online survey of Australian health services . BMC Health Serv Res   2018 ; 18 : 628 .

Google Scholar

Kelly   J , Dwyer   J , Mackean   T , O’Donnell   K , Willis   E . Coproducing Aboriginal patient journey mapping tools for improved quality and coordination of care . Aust J Prim Health   2017 ; 23 : 536 – 542 .

Davies   EL , Bulto   LN , Walsh   A , Pollock   D , Langton   VM , Laing   RE , et al.    Reporting and conducting patient journey mapping research in healthcare: a scoping review . J Adv Nurs   2023 ; 79 : 83 – 100 .

Ly   S , Runacres   F , Poon   P . Journey mapping as a novel approach to healthcare: a qualitative mixed methods study in palliative care . BMC Health Serv Res   2021 ; 21 : 915 .

Arias   M , Rojas   E , Aguirre   S , Cornejo   F , Munoz-Gama   J , Sepúlveda   M , et al.    Mapping the patient’s journey in healthcare through process mining . Int J Environ Res Public Health   2020 ; 17 : 6586 .

Natale   V , Pruette   C , Gerohristodoulos   K , Scheimann   A , Allen   L , Kim   JM , et al.    Journey mapping to improve patient-family experience and teamwork: applying a systems thinking tool to a pediatric ambulatory clinic . Qual Manag Health Care   2023 ; 32 : 61 – 64 .

Cherif   E , Martin-Verdier   E , Rochette   C . Investigating the healthcare pathway through patients’ experience and profiles: implications for breast cancer healthcare providers . BMC Health Serv Res   2020 ; 20 : 735 .

Gilburt   H , Drummond   C , Sinclair   J . Navigating the alcohol treatment pathway: a qualitative study from the service users’ perspective . Alcohol Alcohol   2015 ; 50 : 444 – 450 .

Gichuhi   S , Kabiru   J , M’Bongo Zindamoyen   A , Rono   H , Ollando   E , Wachira   J , et al.    Delay along the care-seeking journey of patients with ocular surface squamous neoplasia in Kenya . BMC Health Serv Res   2017 ; 17 : 485 .

Borycki   EM , Kushniruk   AW , Wagner   E , Kletke   R . Patient journey mapping: integrating digital technologies into the journey . Knowl Manag E-Learn   2020 ; 12 : 521 – 535 .

Barton   E , Freeman   T , Baum   F , Javanparast   S , Lawless   A . The feasibility and potential use of case-tracked client journeys in primary healthcare: a pilot study . BMJ Open   2019 ; 9 : e024419 .

Bearnot   B , Mitton   JA . “You’re always jumping through hoops”: journey mapping the care experiences of individuals with opioid use disorder-associated endocarditis . J Addict Med   2020 ; 14 : 494 – 501 .

Cunnington   MS , Plummer   CJ , McDiarmid   AK , McComb   JM . The patient journey from symptom onset to pacemaker implantation . QJM   2008 ; 101 : 955 – 960 .

Geerse   C , van Slobbe   C , van Triet   E , Simonse   L . Design of a care pathway for preventive blood pressure monitoring: qualitative study . JMIR Cardio   2019 ; 3 : e13048 .

Laveau   F , Hammoudi   N , Berthelot   E , Belmin   J , Assayag   P , Cohen   A , et al.    Patient journey in decompensated heart failure: an analysis in departments of cardiology and geriatrics in the Greater Paris University Hospitals . Arch Cardiovasc Dis   2017 ; 110 : 42 – 50 .

Naheed   A , Haldane   V , Jafar   TH , Chakma   N , Legido-Quigley   H . Patient pathways and perceptions of treatment, management, and control Bangladesh: a qualitative study . Patient Prefer Adherence   2018 ; 12 : 1437 – 1449 .

Bateman   S , Arnold-Chamney   M , Jesudason   S , Lester   R , McDonald   S , O’Donnell   K , et al.    Real ways of working together: co-creating meaningful Aboriginal community consultations to advance kidney care . Aust N Z J Public Health   2022 ; 46 : 614 – 621 .

Greenhalgh   T , Hinton   L , Finlay   T , Macfarlane   A , Fahy   N , Clyde   B , et al.    Frameworks for supporting patient and public involvement in research: systematic review and co-design pilot . Health Expect   2019 ; 22 : 785 – 801 .

Wauben   LSGL , Guédon   ACP , de Korne   DF , van den Dobbelsteen   JJ . Tracking surgical day care patients using RFID technology . BMJ Innov   2015 ; 1 : 59 – 66 .

Tong   A , Sainsbury   P , Craig   J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups . Int J Qual Health Care   2007 ; 19 : 349 – 357 .

von Elm   E , Altman   DG , Egger   M , Pocock   SJ , Gøtzsche   PC , Vandenbroucke   JP , et al.    The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies . Lancet   2007 ; 370 (9596): 1453 – 1457 .

Wilson   A , Mackean   T , Withall   L , Willis   EM , Pearson   O , Hayes   C , et al.    Protocols for an Aboriginal-led, multi-methods study of the role of Aboriginal and Torres Strait Islander health workers, practitioners and Liaison officers in quality acute health care . J Aust Indigenous HealthInfoNet   2022 ; 3 : 1 – 15 .

Lee   B , Lee   J , Cho   Y , Shin   Y , Oh   C , Park   H , et al.    Visualisation of information using patient journey maps for a mobile health application . Appl Sci   2023 ; 13 : 6067 .

Author notes

Email alerts, citing articles via.

• Recommend to Your Librarian
• Advertising and Corporate Services
• Journals Career Network

Affiliations

• Online ISSN 1873-1953
• Print ISSN 1474-5151
• Copyright © 2024 European Society of Cardiology
• About Oxford Academic
• Publish journals with us
• University press partners
• What we publish
• New features  
• Open access
• Institutional account management
• Rights and permissions
• Get help with access
• Accessibility
• Advertising
• Media enquiries
• Oxford University Press
• Oxford Languages
• University of Oxford

Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide

• Copyright © 2024 Oxford University Press
• Cookie settings
• Cookie policy
• Privacy policy
• Legal notice

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This PDF is available to Subscribers Only

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Welcome to MySpire

Manage your personal details, preferences and appointments securely and conveniently.

Your Patient number can be found at the top of any account or appointment email communications you receive from Spire.

Use of MySpire is subject to our Terms. Please tick to confirm that you have read and agree to our Terms and that you have read, understood and agree to the Privacy Notice

Forgotten your password?

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Eur J Hum Genet
• v.28(2); 2020 Feb

“Patient Journeys”: improving care by patient involvement

Matt bolz-johnson.

1 SquareRootThinking and EURORDIS – Rare Diseases Europe, Paris, France

Jelena Meek

2 Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands

Nicoline Hoogerbrugge

“I will not be ashamed to say ‘ I don’t know’ , nor will I fail to call in my colleagues…”. For centuries this quotation from the Hippocratic oath, has been taken by medical doctors. But what if there are no other healthcare professionals to call in, and the person with the most experience of the disease is sitting right in front of you: ‘ your patient ’.

This scenario is uncomfortably common for patients living with a rare disease when seeking out health care. They are fraught by many hurdles along their health care pathway. From diagnosis to treatment and follow-up, their healthcare pathway is defined by a fog of uncertainties, lack of effective treatments and a multitude of dead-ends. This is the prevailing situation for many because for rare diseases expertise is limited and knowledge is scarce. Currently different initiatives to involve patients in developing clinical guidelines have been taken [ 1 ], however there is no common method that successfully integrates their experience and needs of living with a rare disease into development of healthcare services.

Even though listening to the expertise of a single patient is valuable and important, this will not resolve the uncertainties most rare disease patients are currently facing. To improve care for rare diseases we must draw on all the available knowledge, both from professional experts and patients, in order to improve care for every single patient in the world.

Patient experience and satisfaction have been demonstrated to be the single most important aspect in assessing the quality of healthcare [ 2 ], and has even been shown to be a predictor of survival rates [ 3 ]. Studies have evidenced that patient involvement in the design, evaluation and designation of healthcare services, improves the relevance and quality of the services, as well as improves their ability to meet patient needs [ 4 – 6 ]. Essentially, to be able to involve patients, the hurdles in communication and initial preconceptions between medical doctors and their patients need to be resolved [ 7 ].

To tackle the current hurdles in complex or rare diseases, European Reference Networks (ERN) have been implemented since March 2017. The goal of these networks is to connect experts across Europe, harnessing their collective experience and expertise, facilitating the knowledge to travel instead of the patient. ERN GENTURIS is the Network leading on genetic tumour risk syndromes (genturis), which are inherited disorders which strongly predispose to the development of tumours [ 8 ]. They share similar challenges: delay in diagnosis, lack of cancer prevention for patients and healthy relatives, and therapeutic. To overcome the hurdles every patient faces, ERN GENTURIS ( www.genturis.eu ) has developed an innovative visual approach for patient input into the Network, to share their expertise and experience: “Patient Journeys” (Fig.  1 ).

Example of a Patient Journey: PTEN Hamartoma Tumour Syndrome (also called Cowden Syndrome), including legend page ( www.genturis.eu )

The “Patient Journey” seeks to identify the needs that are common for all ‘ genturis syndromes ’, and those that are specific to individual syndromes. To achieve this, patient representatives completed a mapping exercise of the needs of each rare inherited syndrome they represent, across the different stages of the Patient Journey. The “Patient Journey” connects professional expert guidelines—with foreseen medical interventions, screening, treatment—with patient needs –both medical and psychological. Each “Patient Journey” is divided in several stages that are considered inherent to the specific disease. Each stage in the journey is referenced under three levels: clinical presentation, challenges and needs identified by patients, and their goal to improve care. The final Patient Journey is reviewed by both patients and professional experts. By visualizing this in a comprehensive manner, patients and their caregivers are able to discuss the individual needs of the patient, while keeping in mind the expertise of both professional and patient leads. Together they seek to achieve the same goal: improving care for every patient with a genetic tumour risk syndrome.

The Patient Journeys encourage experts to look into national guidelines. In addition, they identify a great need for evidence-based European guidelines, facilitating equal care to all rare patients. ERN GENTURIS has already developed Patient Journeys for the following rare diseases ( www.genturis.eu ):

• PTEN hamartoma tumour syndrome (PHTS) (Fig.  1 )
• Hereditary breast and ovarian cancer (HBOC)
• Lynch syndrome
• Neurofibromatosis Type 1
• Neurofibromatosis Type 2
• Schwannomatosis

A “Patient Journey” is a personal testimony that reflects the needs of patients in two key reference documents—an accessible visual overview, supported by a detailed information matrix. The journey shows in a comprehensive way the goals that are recognized by both patients and clinical experts. Therefore, it can be used by both these parties to explain the clinical pathway: professional experts can explain to newly identified patients how the clinical pathway generally looks like, whereas their patients can identify their specific needs within these pathways. Moreover, the Patient Journeys could serve as a guide for patients who may want to write, in collaboration with local clinicians, diaries of their journeys. Subsequently, these clinical diaries can be discussed with the clinician and patient representatives. Professionals coming across medical obstacles during the patient journey can contact professional experts in the ERN GENTURIS, while patients can contact the expert patient representatives from this ERN ( www.genturis.eu ). Finally, the “Patient Journeys” will be valuable in sharing knowledge with the clinical community as a whole.

Our aim is that medical doctors confronted with rare diseases, by using Patient Journeys, can also rely on the knowledge of the much broader community of expert professionals and expert patients.

Acknowledgements

This work is generated within the European Reference Network on Genetic Tumour Risk Syndromes – FPA No. 739547. The authors thank all ERN GENTURIS Members and patient representatives for their work on the Patient Journeys (see www.genturis.eu ).

Compliance with ethical standards

The authors declare that they have no conflict of interest.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Book your appointment

Already have a myspire account, i don't have an account.

Once you’ve booked your appointment, we’ll create your Patient ID. You can use this to set up a MySpire account to manage your appointments and personal details.

Instructions for Use

For a complete copy of the Instructions for Use for the Spire RPM system, please contact Technical Support at 1-(415)510-2551 ext. 2.

To learn how the Spire RPM service can benefit your practice

© 2024 Spire Health     ‍ Terms & Conditions       Privacy Policy

Welcome to Spire Connect

Log-in to send referrals to spire healthcare hospitals.

To register for Spire Connect use the link below. Shortly after you register, we'll send you an email with an account activation link. Click on the link in the email to activate the account.